Saxagliptin: a novel antiparkinsonian approach (Q46371308)

scientific article

Language	Label	Description	Also known as
English	Saxagliptin: a novel antiparkinsonian approach	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/25446674

title

Saxagliptin: a novel antiparkinsonian approach (English)

1 reference

stated in

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/25446674

author

Hany H. Arab

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

25446674

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25446674%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

author name string

Noha N Nassar

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

25446674

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25446674%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

Muhammad Y Al-Shorbagy

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

25446674

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25446674%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

Dalaal M Abdallah

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

25446674

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25446674%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

publication date

1 February 2015

1 reference

stated in

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/25446674

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

stated in

Europe PubMed Central

PubMed ID

25446674

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25446674%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

volume

89

1 reference

stated in

Europe PubMed Central

PubMed ID

25446674

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25446674%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

page(s)

308-317

1 reference

stated in

Europe PubMed Central

PubMed ID

25446674

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25446674%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

Identifiers

DOI

10.1016/J.NEUROPHARM.2014.10.007

1 reference

stated in

Europe PubMed Central

PubMed ID

25446674

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25446674%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

Europe PubMed Central

PubMed ID

25446674

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25446674%20AND%20SRC:MED&resulttype=core&format=json

Saxagliptin: a novel antiparkinsonian approach (Q46371308)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Saxagliptin: a novel antiparkinsonian approach (Q46371308)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search